Mondo ng'ato oyud thieth mar tuwo mar sukari, dwarore ni oti gi yore mang'eny moriwo loko kit ngima ng'ato, tiyo gi yedhe, kendo ng'iyo tuwo mar sukari kinde ka kinde.
Magi gin moko kuom gik minyalo tim mondo ikony ng'ato loyo tuwo mar sukari:
1. Lokruok ma timore e kit ngima ng'ato:
- Chiem kit chiemo mowinjore: Yier chiemo ma ok oting'o mafuta mang'eny, kendo ma nigi fiber mang'eny, kaka olembe, alode, kod cham mamoko.
- Tim exercise kinde ka kinde: Tem timo exercise mar dakika 30 e odiechienge mang'eny e juma, kaka wuotho mos.
- Bed gi del mapek: Kethruok mar del nyalo konyo e miyo ng'ato obed gi insulin maber kendo miyo remo obed gi sukari mang'eny.
- We madho ndawa: Madho ndawa miyo ng'ato bedo gi hinyruok mar bedo gi tuwo mar sukari.
2. Tiyo gi yedhe:
- Yath mitiyogo e dho ng'ato: Yathgo nyalo konyo e dwoko piny teko mar sukari e remo kuom miyo insulin omed bedo mang'eny, miyo insulin obed mang'eny, kata miyo glucose obed mang'eny.
- Insulin therapy: Insulin injection kata insulin pump nyalo dwarore kuom joma nigi type 1 diabetes kod moko ma nigi type 2 diabetes.
3. Rito gik matimore
- Nono kaka remo oting'o sukari kinde ka kinde: Non kaka remo oting'o sukari kaluwore gi kaka laktar osejiwi.
- Nono kinde ka kinde: Dhi ir laktar mondo ononi kinde ka kinde mondo one ni in gi tuwo mar sukari kod chal mari mar ngima.
4. Tiyo gi yore mopogore opogore mag geng'o tuoche:
- Bed gi teko mar remo kod cholesterol e bwo teko mondo kik iyud tuwo mar adundo kata tuwo mar strok.
- Rit tiendeni mondo igeng' hinyruok mar obwongo kod tuoche.
- Nono wang' ji kinde ka kinde mondo ong'e kendo thiedh tuwo mar diabetic retinopathy.
5. konyruok:
- Dhi e grup moro mar joma nigi tuwo mar sukari kata wuo gi ng'at ma chiwo paro mondo okonyi nyagori gi chandruoge ma ng'ato yudo sama en gi tuwo mar sukari.
- Ti gi ng'at molony e weche mag tuwo mar sukari mondo ing'e weche momedore e wi kaka inyalo geng'o tuwoni.
Ng'e ni en gima dwarore ahinya ni iti kanyachiel gi laktar mondo iyud yore mag thieth mowinjore kodi.
Handorf AM, Sollinger HW, Alam T: Insulin gene therapy for type 1 diabetes mellitus. Exp Clin Transplant. 2015, 13 Suppl 1 (): 37-45.
Galakhov EV, Zhiliaeva EP: [Problems concerning the training of feldshers in foreign countries]. Feldsher Akush. 1975, 40 (9): 37-41.
Ceriello A, Barkai L, Christiansen JS, Czupryniak L, Gomis R, Harno K, Kulzer B, Ludvigsson J, Némethyová Z, Owens D, Schnell O, Tankova T, Taskinen MR, Vergès B, Weitgasser R, Wens J: Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract. 2012, 98 (1): 5-10.
McElduff A: Type 2 diabetes mellitus: an evolving therapeutic approach. P N G Med J. , 44 (3-4): 124-30.
Koskinas K, Melmer A, Steiner N, Gübeli A, Wilhelm M, Laimer M: [Diagnosis, Prevention and Treatment of Cardiovascular Disease in People with Diabetes and Prediabetes]. Praxis (Bern 1994). 2021, 110 (1): 37-47.
Filippi CM, von Herrath MG: Strategies to treat autoimmune diabetes. Expert Rev Endocrinol Metab. 2007, 2 (2): 185-194.
Tibaldi J: Intensifying treatment in poorly controlled type 2 diabetes mellitus: case reports. Am J Med. 2008, 121 (6 Suppl): S30-4.
Verrotti A, Chiuri RM, Blasetti A, Mohn A, Chiarelli F: Treatment options for paediatric diabetes. Expert Opin Pharmacother. 2010, 11 (15): 2483-95.
Nadeau DA: Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes. Postgrad Med. 2010, 122 (3): 7-15.
Ng'at ma kwedo weche mag thieth
Websaitni olos mondo okony ji ng'eyo weche mag thieth, to ok mondo okonygi ng'eyo kaka ginyalo tiyo gi yore mag thieth.
Weche mochiw ok onego oti kodgi e fwenyo kata thiedho tuwo moro, kendo jogo madwaro ng'eyo kaka ginyalo thiedho tuwo moro, onego owuo gi laktar molony.
Ng'e ni neural net ma chiwo dwoko mag penjo, ok en makare ahinya sama iwuoyo kuom kwan mag ji, kaka kwan mar joma nigi tuwo moro.
Kinde duto many paro mar laktar kata ng'at machielo molony e weche thieth e wi tuwo moro. Kik iket kiawa kuom paro mar laktar kata duoko chien kwayo mar thieth nikech gimoro ma isomo e websaitni. Kapo ni iparo ni inyalo bedo gi chandruok mar thieth, luong 911 kata dhi e od thieth machiegni mapiyo. Onge tudruok moro amora e kind laktar gi jatuwo ma yudore e websaitni kata e tiyo kode. BioMedLib kata jotichne, kata ng'ato ang'ata ma konyo e websaitni, ok nyal chiwo paro moro amora, kata ma ok ong'ere, e wi weche ma yudore e websaitni kata e tiyo kode.
Ng'eyo ni ng'ato nigi ratiro mar timo gik moko
Digital Millennium Copyright Act mar 1998, 17 U.S.C. § 512 (the DMCA) chiwo yore mag kony ne joma nigi ratiro mag ndiko ma paro ni weche ma yudore e Intanet ketho ratiro ma gin-go kaluwore gi chike mag ndiko mag piny Amerka.
Kapo ni iyie gi adiera ni weche moro amora ma yudore e websait marwa kata e tijewa ketho ratiro ma in-go mar ndiko weche, in (kata ng'at mochung'ne) inyalo oronwa barua ka ikwayo ni ogol weche ma yudore e websaitno, kata mondo ogeng' ng'ato kik yudgi.
Weche ma ng'ato onego owach nyaka oor e yo mondik kokalo kuom e-mail (ne "Contact" e wi adres mar e-mail).
DMCA dwaro ni ng'eyo ma in-go kuom ketho chik mar copyrights oting'o weche maluwogi: (1) ler mar tij copyrights ma ikwano ni oketho; (2) ler mar weche ma ikwano ni oketho chik mar copyrights kod weche moromo mondo okonywa ng'eyo kama wechego nitie; (3) weche mag tudruok kodi, moriwo adresni, namba mar simo kod adres mar email; (4) weche ma in-go manyiso ni in gi yie maber ni weche ma ondik e yo ma ikwedo ok oyie gi jal ma nigi ratiro mar copyrights, kata gi ng'at mochung'ne, kata gi chik moro amora;
(5) weche ma in iwuon iwacho, ma iketo e bwo buch kuong'ruok, ni weche manie kalatasno gin adier, kendo ni in gi teko mar tiyo gi ratiro mag ndiko ma ji wacho ni oketh;
(6) kod signature mar ng'at ma nigi ratiro mar timo gik moko, kata ng'at ma nigi ratiro mar timo gik moko e lo ng'at ma nigi ratiro mar timo gik moko.
Ka ok iketo weche duto monyis malo kae, mano nyalo miyo idonj e kesno bang'e.
Wuo gi ng'at machielo
Ka in gi penjo kata paro moro amora, yie iornwa e-mail.
How to treat diabetes?
To treat diabetes, it is important to follow a comprehensive approach that includes lifestyle changes, medication, and regular monitoring.
Here are some steps that can help manage diabetes:
1. Lifestyle changes:
- Eat a healthy diet: Choose foods that are low in fat and calories, and high in fiber, such as fruits, vegetables, and whole grains.
- Exercise regularly: Aim for at least 30 minutes of moderate-intensity physical activity, such as brisk walking, most days of the week.
- Maintain a healthy weight: Losing weight can help improve insulin sensitivity and blood sugar control.
- Quit smoking: Smoking increases the risk of diabetes-related complications.
2. Medication:
- Oral medications: These can help lower blood sugar levels by increasing insulin production, increasing insulin sensitivity, or decreasing glucose absorption.
- Insulin therapy: Insulin injections or an insulin pump may be necessary for people with type 1 diabetes and some with type 2 diabetes.
3. Monitoring:
- Regular blood sugar testing: Check your blood sugar levels as recommended by your healthcare provider.
- Regular checkups: Visit your healthcare provider for regular checkups to monitor your diabetes and overall health.
4. Manage complications:
- Keep your blood pressure and cholesterol under control to reduce the risk of heart disease and stroke.
- Take care of your feet to prevent nerve damage and infections.
- Regular eye exams to detect and treat diabetic retinopathy.
5. Support:
- Join a support group or talk to a counselor to help manage the emotional aspects of living with diabetes.
- Work with a diabetes educator to learn more about managing your condition.
Remember, it is important to work closely with your healthcare provider to develop a personalized treatment plan that works best for you.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Chiegni ni
BioMedLib tiyo gi kompyuta ma tiyo gi masinde (ma iluongo ni machine-learning algorithms) e loso penjo gi dwoko.
Ne wachako gi buge milion 35 mag weche thieth miluongo ni PubMed/Medline. Bende, ne wachako gi buge mag RefinedWeb.
